1. Purpose & Objectives
The primary objective of this Content Review Policy (CRP) is to define a structured review framework for all digital assets published on the National Pharmaceutical Pricing Authority (NPPA) portal. In compliance with the Guidelines for Indian Government Websites (GIGW), this policy ensures that pricing models, data registers, and compliance directives remain meticulously updated, factually precise, and legally sound to prevent misinterpretation by public and industrial stakeholders.
2. Scope & Applicability
This policy strictly applies to all digital representations hosted on the official NPPA framework, encompassing:
- Statutory Notifications, including Ceiling and Retail Price fixations under the Drug Price Control Order (DPCO).
- Form-IV, Form-V compliance registers, monitoring charts, and pharmaceutical market surveillance summaries.
- Public advisories, technical executive reports, dynamic tenders, and institutional announcements.
3. Review Frequency Framework
To circumvent structural out-of-date information blocks, data is systematically segmented into designated review schedules:
| Content Type | Review Interval | Responsibility Unit | Critical Verification Parameters |
|---|---|---|---|
| DPCO Ceiling / Retail Price Orders | Quarterly / Event-driven | Pricing Division Team | Cross-match with official gazette publications and formulas. |
| National List of Essential Medicines (NLEM) Matrix | Semi-Annually | Pharma & Legal Division | Validate sync against Ministry of Health amendments. |
| Public Advisories & Legal Notices | Bi-Monthly | Legal Cell Advisors | Verify judicial standing and open public advisory windows. |
| Corporate Static Pages (About, Schemes) | Annually | Appointed Portal Admin | Update structural mandates and internal staff portfolios. |
4. Multi-Layer Review Workflow Matrix
The CRP workflow functions across three distinctive internal operations tiers:
4.1. Level-1 Technical Validation
Performed by the assigned operational desk. Checks focus explicitly on semantic integrity, broken URL paths, formatting discrepancies, and accessibility tags.
4.2. Level-2 Domain & Legal Evaluation
Directed by specialized sectional leaders. Reviews assess accuracy against active regulatory statutes, ensuring technical drug calculations mirror active working datasets.
4.3. Level-3 Final Authorization
Sanctioned by senior NPPA IT/Web Content Leads. Validates completion of all checks before deploying refreshed cache layers.
5. Hyperlink & Interoperability Health Controls
All hyperlinked dependencies connecting to external portals (such as Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, or NIC gateways) must undergo scheduled automated checks. Broken or orphaned endpoints must be flagged and rectified within a 24-hour corrective operational window to protect the integrity of the user experience.
6. Compliance & Log Metrics
Every review transaction registers an immutable, digital cryptographic log track detailing the date of review, identifying token of the individual reviewer, notes on corrections executed, and scheduled timeline for the successive iteration cycle.
